Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proinsulin C-peptide--a consensus statement.

A A Sima1, G Grunberger, H Jörnvall

  • 1Department of Pathology, and Morris Hood Jr. Diabetes Center, Wayne State University, Detroit, Michigan, USA. asima@med.wayne.edu

International Journal of Experimental Diabetes Research
|October 9, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomized clinical trial of basal insulin peglispro vs NPH in insulin-naïve patients with type 2 diabetes: the IMAGINE 6 trial.

Diabetes, obesity & metabolism·2016
Same author

Early fasting glucose measurements can predict later glycaemic response to once weekly dulaglutide.

Diabetic medicine : a journal of the British Diabetic Association·2015
Same author

Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab).

Journal of the peripheral nervous system : JPNS·2014
Same author

The need for better insulin therapy.

Diabetes, obesity & metabolism·2013
Same author

Monotherapy with the once-weekly GLP-1 analogue dulaglutide for 12 weeks in patients with Type 2 diabetes: dose-dependent effects on glycaemic control in a randomized, double-blind, placebo-controlled study.

Diabetic medicine : a journal of the British Diabetic Association·2012
Same author

Diabetic neuropathy: pathogenetic background, current and future therapies.

Expert review of neurotherapeutics·2009
Same journal

Effect of mild hypoinsulinemia on renal hypertrophy: growth hormone/insulin-like growth factor I system in mild streptozotocin diabetes.

International journal of experimental diabetes research·2003
Same journal

The role of reactive oxygen species in diabetes-induced anomalies in embryos of Cohen diabetic rats.

International journal of experimental diabetes research·2003
Same journal

C-peptide prevents hippocampal apoptosis in type 1 diabetes.

International journal of experimental diabetes research·2003
Same journal

Effect of acipimox on plasma lipids and glucose/insulin in pregnant rats.

International journal of experimental diabetes research·2003
Same journal

Alteration of endothelins: a common pathogenetic mechanism in chronic diabetic complications.

International journal of experimental diabetes research·2003
Same journal

Protein tyrosine phosphatase 1B is impaired in skeletal muscle of diabetic Psammomys obesus.

International journal of experimental diabetes research·2002
See all related articles

Proinsulin C-peptide replacement shows therapeutic potential for type 1 diabetes complications. Further research is recommended to establish its biological actions and clinical usefulness in diabetes management.

Area of Science:

  • Endocrinology and Metabolism
  • Diabetology
  • Molecular Physiology

Background:

  • Growing evidence suggests a significant physiological role for proinsulin C-peptide beyond its function as an insulin production marker.
  • Type 1 diabetes is associated with a deficiency in C-peptide, contributing to diabetic complications.
  • C-peptide replacement therapy is being investigated as a potential treatment strategy.

Framework:

  • A review of cellular, physiological, and clinical effects of C-peptide replacement.
  • Analysis of data from animal models and human clinical studies in type 1 diabetes.
  • Consolidation of current knowledge and identification of future research directions.

Implementation:

  • Review of studies examining C-peptide's effects on cellular function and signaling pathways.

Related Experiment Videos

  • Evaluation of C-peptide's impact on physiological parameters in diabetic models and patients.
  • Assessment of clinical outcomes associated with C-peptide administration.

    • Implications:

    • C-peptide replacement may offer a novel therapeutic approach to prevent and treat type 1 diabetic complications.
    • Further research is crucial to fully elucidate C-peptide's biological mechanisms and optimize its clinical application.
    • Establishing C-peptide's therapeutic value could significantly improve the management of type 1 diabetes.